Community Pharmacists' Involvement in Smoking Cessation Familiarity and Implementation of the N

来源 :BITs 3rd Annual World Cancer Congress-2012(2012第五届世界癌症大会) | 被引量 : 0次 | 上传用户:pyh333
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Since 2002, the Finnish National Current Care Guideline of Smoking cessation (SC) has defined specified tasks for community pharmacists in SC accordingly with other health-care professionals.All health-care professionals have specified responsibilities, and the local cooperation between them should facilitate SC by increasing contacts with patients.The role of community pharmacies revolve around supporting rational use of nicotine replacement therapy products and other SC medicines.Finnish community pharmacies are privately owned by pharmacists and highly regulated to emphasize public health goals in their operations.The staff in Finnish Community pharmacies is also highly educated.A nationwide mail survey was conducted to study (total n=2291) the familiarity and implementation on the National SC guideline in Finnish community pharmacies.Response rate was 54% (n=1190).Almost half (47%)of the respondents were familiar with the SC Guideline and familiarity enhanced implementation.The familiarity was associated with the respondents perceptions of their personal smoking cessation skills and knowledge (OR 3,8);of customers value of counseling on nicotine replacement therapy (OR3,3) and regular use of pocket cards supporting SC counseling (OR 3,0).Smoking cessation Guideline familiarity and implementation is crucial role for community pharmacist involvement in SC actions in addition to selling nicotine replacement product.Nicotine replacement therapy products were deregulated in Finland in 2006, which complicated community pharmacists involvement in supporting cessation, because quitters do not necessarily visit pharmacies for product purchases.Smoking is still common in Finland and community pharmacies contribution to SC in collaboration with other primary care providers is needed.
其他文献
Tumor initiation and progression are driven by a subpopulation of tumor cells that possess stem cell properties and are resistant to traditional cancer treatments—the cancer stem cells (CSCs).CSCs hav
会议
Deregulated activation of tyrosine kinases plays an important role in the initiation and propagation of many hematological and solid tumors.Lapatinib is a highly selective dual inhibitor of ErbB2 (HER
会议
We previously found that the expression of inhibitor of differentiation 1 (ID1) was elevated in breast cancer cells after long-term exposure to fulvestrant, an antagonist of ESR1.In this study, we dem
会议
Imprime PGG(R) Injection (Imprime PGG) is an immunomodulatory beta-glucan polymer isolated from a proprietary stain of Saccharomyces cerevisiae that selectively binds to complement receptor 3 (CR3) on
会议
Cancer stem cells are considered as an origin of cancer.Cancer stem cells can cause tumors in mice models.Recent studies proved the efficacy of some promising therapies to treat cancers.Dendritic cell
会议
Previous studies of chordoma have focused on either surgery, radiotherapy, or particular tumor locations.This paper reviewed the outcomes of surgery and proton radiotherapy with various tumor location
会议
S-1 is a new oral fluoropyrimidine anticancer agent shown to be effective for pancreatic cancer.In a previous phase I trial, we evaluated the safety of S-1 combined with radiotherapy to determine the
会议
The pervasiveness of mobile technology suggests that incorporating these platforms into smoking cessation has substantial potential to both reach and engage teens and young adults in quitting smoking.
会议
It has been demonstrated that tobacco is the public health enemy number one and is responsible for over five million deaths worldwide.It is the number one risk factor to the top leading causes of deat
会议
Smoking prevalence in homeless populations is strikingly high (~ 70%), yet little is known about effective smoking cessation interventions for this population.We conducted a community-based clinical t
会议